Sutro Biopharma, Inc. (STRO) stock
STRONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$8.92−0.40 (-4.29%)
Close on Nov 17, 2026Market cap $147.90MP/E –Yield –
Sutro Biopharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Sutro Biopharma's pe ratio was 66.8× on Jan 29, 2021.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Jan 29, 2021 | 66.8× | +1.3 |
| 2020 | Dec 31, 2020 | 65.5× | – |
See a number that looks wrong?